No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - OptiBiotix Health announced the launch of multiple SlimBiome-containing products under its GoFigure brand on Amazon India on Monday, marking a strategic expansion into the country's rapidly growing weight management market.
The AIM-traded firm said the initiative was part of its broader multi-channel strategy aimed at increasing product sales through both online and in-store channels.
India, now the world's most populous nation, was projected to have the largest cohort of medium- to high-income consumers by 2035.
With obesity prevalence currently at 40.3%, the board said the market presented significant opportunities for weight management solutions.
OptiBiotix said its wholly-owned OptiBiotix India subsidiary would sell GoFigure products via Amazon, in addition to their existing presence in Apollo Pharmacies and on Apollo's e-commerce platform.
The launch on Amazon India coincided with a rebranding of the product's packaging and a relaunch in Apollo pharmacies.
OptiBiotix said the new design featured more vibrant colours to enhance visibility, and included prominent branding of Tata's Fossence, a locally-recognised ingredient aimed to enhance consumer trust and familiarity.
The GoFigure range is manufactured in India using local suppliers, incorporating Tata's proprietary Fossence prebiotic ingredient.
"Launching products on Amazon India is another step forward in building a presence for the Company's products in the strategically important Indian market," said chief executive officer Stephen O'Hara.
"We are now building SlimBiome's presence across India via our own brand products through Amazon India and via Apollo pharmacies, and as private label partnerships following the recent launch by Dr Morepen.
"This initial launch will include four products with subsequent launches taking place throughout 2025 dependent on sales progress."
At 1515 GMT, shares in OptiBiotix Health were up 5.41% at 17.92p.
Reporting by Josh White for Sharecast.com.
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.